Prosecution Insights
Last updated: April 19, 2026

SK Biopharmaceuticals Co. Ltd.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
3
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18565188 METHODS FOR TREATING AUTISM SPECTRUM DISORDERS (ASD) ROZOF, TIMOTHY R 1625 Non-Final OA Nov 29, 2023
18210215 BLEND CONTAINING CARBAMATE COMPOUND FOR PREVENTION, MITIGATION, OR TREATMENT OF SCHIZOPHRENIA SAEED, KAMAL A 1626 Final Rejection Jun 15, 2023
18207401 BICYCLIC COMPOUND AND USE THEREOF HABTE, KAHSAY 1624 Non-Final OA Jun 08, 2023
18122780 BICYCLIC COMPOUND AND USE THEREOF HABTE, KAHSAY 1624 Non-Final OA Mar 17, 2023
18019856 SOLID ORAL COMPOSITION COMPRISING CARBAMATE COMPOUND, AND PREPARATION METHOD THEREFOR TRAN, SUSAN T 1615 Final Rejection Feb 06, 2023
18157953 ORAL PHARMACEUTICAL COMPOSITION COMPRISING CARBAMATE COMPOUND AND PREPARATION METHOD THEREFOR ATKINSON, JOSHUA ALEXANDER 1612 Non-Final OA Jan 23, 2023
17770704 USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUND FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DEVELOPMENTAL DISABILITY SEITZ, ANTHONY JOSEPH 1629 Final Rejection Apr 21, 2022
17770686 USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUNDS FOR PREVENTION, ALLEVIATION, OR TREATMENT OF COGNITIVE DISORDERS, OR FOR IMPROVING COGNITIVE FUNCTION RAO, PADMAJA S 1627 Non-Final OA Apr 21, 2022

Managing SK Biopharmaceuticals Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month